UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

The Lancet (British edition), 2007-12, Vol.370 (9602), p.1847-1853

2007

Volltextzugriff (PDF)

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

Vaccine, 2010-01, Vol.28 (3), p.834-839

2010

Volltextzugriff (PDF)

Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073

Vaccine, 2008-07, Vol.26 (31), p.3818-3826

2008

Volltextzugriff (PDF)

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study

Vaccine, 2008-08, Vol.26 (34), p.4382-4386

2008

Volltextzugriff (PDF)

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

HemaSphere, 2022-06, Vol.6, p.97-98

2022

Volltextzugriff (PDF)

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients

Vaccine, 2009-05, Vol.27 (23), p.3099-3108

2009

Volltextzugriff (PDF)

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX® 1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

Vaccine, 2009-07, Vol.27 (33), p.4483-4489

2009

Volltextzugriff (PDF)

Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis

Proteomics (Weinheim), 2002-05, Vol.2 (5), p.580-590

2002

Volltextzugriff (PDF)

1203 CLONAL SEQUENCING OF HCV NS3 PROTEASE AND HELICASE T CELL EPITOPES IN PATIENTS IMMUNIZED WITH THE THERAPEUTIC HCV VACCINE IC41

Journal of hepatology, 2011-03, Vol.54, p.S475-S475

2011

Volltextzugriff (PDF)

Long term immunogenicity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO®, IC51

International journal of infectious diseases, 2010, Vol.14, p.e449-e449

2010

Volltextzugriff (PDF)

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

Vaccine, 2008, Vol.26 (34), p.4382-4386

2008

Volltextzugriff (PDF)

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

Proteomics (Weinheim), 2001-07, Vol.1 (7), p.890-898

2001

Volltextzugriff (PDF)

PS1457 MAINTENANCE OF RESPONSE IN LONG‐TERM TREATMENT WITH ROPEGINTERFERON ALFA‐2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION‐PV PHASE III TRIALS)

HemaSphere, 2019-06, Vol.3 (S1), p.670-671

2019

Volltextzugriff (PDF)

A new synthesis of substituted furans

Journal of the American Chemical Society, 1989-06, Vol.111 (12), p.4407-4413

1989

Volltextzugriff (PDF)

14 Cross-genotype-reactivity of the immunodominant HCV-CD8 T-cell epitope NS3-1073: Significance for the development of peptide-based vaccines against HCV

Journal of hepatology, 2006-04, Vol.44, p.S8-S8

2006

Volltextzugriff (PDF)

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine : a non-inferiority, phase III , randomised controlled trial. Commentary

The Lancet (British edition), 2007, Vol.370 (9602)

2007

Volltextzugriff (PDF)

Spontaneous clearance of hepatitis C viremia in the absence of humoral immunity and very low levels of cellular HCV-specific immunity

Zeitschrift für Gastroenterologie, 2006, Vol.44 (8)

2006

Volltextzugriff (PDF)

Frequency and functional analysis of variants of the immunodominant epitope NS3–1073: Relevance for vaccine design

Zeitschrift für Gastroenterologie, 2006, Vol.44 (8)

2006

Volltextzugriff (PDF)

Phänotypische Charakterisierung von HCV-spezifischen CD8+ T-Zellen nach HCV-Peptidimpfung vs. akute und chronische Hepatitis C

Zeitschrift für Gastroenterologie, 2006, Vol.44 (1)

2006

Volltextzugriff (PDF)

Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma

International journal of cancer, 2002-01, Vol.97 (2), p.217-224

2002

Volltextzugriff (PDF)

Proteomics approaches towards antigen discovery and vaccine development

Current opinion in molecular therapeutics, 2002-06, Vol.4 (3), p.216

Klade, Christoph S

2002

Volltextzugriff (PDF)

Klade CS, Dohnal A, Furst W, Sommergruber W, Heider KH, Gharwan H, Ratschek M, Adolf GR. Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma. International Journal of Cancer 2002;97(2): 217–224

International journal of cancer, 2002-04, Vol.98 (6), p.956-956

2002

Volltextzugriff (PDF)

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

Leukemia, 2022-05, Vol.36 (5), p.1408-1411

2022

Volltextzugriff (PDF)

ChemInform Abstract: A New Synthesis of Substituted Furans

ChemInform, 1989-10, Vol.20 (40), p.no-no

1989

Volltextzugriff (PDF)

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Blood, 2015-10, Vol.126 (15), p.1762-1769

2015

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(41)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Biological And Medical Sciences
(13)
Female
(11)
Medical Sciences
(11)
Male
(10)
Middle Aged
(10)
Infectious Diseases
(9)
Adult
(8)
Aged
(8)
Microbiology
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(6)
Aged, 80 And Over
(5)
Allergy And Immunology
(5)
Animals
(5)
Applied Microbiology
(5)
Hematology
(5)
Human Viral Diseases
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX® 1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis

1203 CLONAL SEQUENCING OF HCV NS3 PROTEASE AND HELICASE T CELL EPITOPES IN PATIENTS IMMUNIZED WITH THE THERAPEUTIC HCV VACCINE IC41

Long term immunogenicity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO®, IC51

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

PS1457 MAINTENANCE OF RESPONSE IN LONG‐TERM TREATMENT WITH ROPEGINTERFERON ALFA‐2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION‐PV PHASE III TRIALS)

A new synthesis of substituted furans

14 Cross-genotype-reactivity of the immunodominant HCV-CD8 T-cell epitope NS3-1073: Significance for the development of peptide-based vaccines against HCV

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine : a non-inferiority, phase III , randomised controlled trial. Commentary

Spontaneous clearance of hepatitis C viremia in the absence of humoral immunity and very low levels of cellular HCV-specific immunity

Frequency and functional analysis of variants of the immunodominant epitope NS3–1073: Relevance for vaccine design

Phänotypische Charakterisierung von HCV-spezifischen CD8+ T-Zellen nach HCV-Peptidimpfung vs. akute und chronische Hepatitis C

Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma

Proteomics approaches towards antigen discovery and vaccine development

Klade CS, Dohnal A, Furst W, Sommergruber W, Heider KH, Gharwan H, Ratschek M, Adolf GR. Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma. International Journal of Cancer 2002;97(2): 217–224

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

ChemInform Abstract: A New Synthesis of Substituted Furans

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Suchergebnisse filtern